InsiderClue
← All stocks

Vera Therapeutics, Inc.

VERA Net buying
CIK 0001831828 #1966 in the set updated 21 Sep 2026
Bought (120 mo)
$115.15M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$85.68M
$6.45M on a plan · $23.40M straight out of an exercise
Sold at will
$55.83M
23 of 184 sales
Net
+$29.47M
+$59.33M against sales at will

By person

22 insiders · 239 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ENRIGHT PATRICK G
Director
$32.53M (8)
—
+$32.53M
6,699,069
9.30%
$247.87M
+415.7%
Longitude Capital Partners IV, LLC entity
10% owner
$27.00M (3)
—
+$27.00M
4,810,879
6.68%
$178.00M
—
Katabi Maha
Director
$13.00M (2)
$34.10M (6)
−$21.10M
5,708,763
7.92%
$211.22M
+64.7%
Fordyce Marshall
PRESIDENT AND CEO
—
$20.40M (85) scheduled
−$20.40M
235,244
0.3264%
$8.70M
+5,703%
Sofinnova Venture Partners X, L.P. entity
10% owner
$14.00M (3)
—
+$14.00M
3,467,156
4.81%
$128.28M
—
COMMODORE CAPITAL LP entity
10% owner
$6.80M (1)
$18.90M (1)
−$12.10M
4,400,000
6.11%
$162.80M
−12.0%
EMSTER KURT VON
Director
$8.71M (2)
—
+$8.71M
2,978,059
4.13%
$110.19M
—
Abingworth LLP
10% owner
$8.50M (1)
—
+$8.50M
2,960,231
4.11%
$109.53M
—
Grant Sean
CHIEF FINANCIAL OFFICER
$251.00K (6)
$4.90M (20) scheduled
−$4.65M
119,181
0.1654%
$4.41M
+1,548%
SEIDENBERG BETH C
Director
$4.32M (19)
$1.42M (5) scheduled
+$2.90M
1,478,717
2.05%
$54.71M
—
Young Joseph R
SVP, FINANCE, CHIEF ACCT OFFCR
$40.00K (1)
$2.10M (7) scheduled
−$2.06M
80,754
0.1121%
$2.99M
+882.3%
Curley Joanne
Chief Development Officer
—
$1.82M (48) scheduled
−$1.82M
26,962
0.0374%
$997.59K
+0.5%
Turner William D.
Chief Regulatory Officer
—
$1.45M (4) scheduled
−$1.45M
45,313
0.0629%
$1.68M
—
Carlyle Group Inc. entity
10% owner
—
$201.03K (3) scheduled
−$201.03K
2,960,231
4.11%
$109.53M
0.0%
JOHNSON DAVID LEE
Chief Operating Officer
—
$108.28K (1)
−$108.28K
45,727
0.0635%
$1.69M
+3,152%
Carter Jason S
Chief Legal Officer
—
$107.50K (1)
−$107.50K
49,136
0.0682%
$1.82M
—
Brenner Robert
Chief Medical Officer
—
$90.31K (1)
−$90.31K
50,947
0.0707%
$1.89M
+4,153%
Skelton Laurence Matthew
Chief Commercial Officer
—
$66.42K (1)
−$66.42K
64,218
0.0891%
$2.38M
+40.2%
Lin Celia
Chief Medical Officer
—
$24.82K (1) scheduled
−$24.82K
11,010
0.0153%
$407.37K
—
Boman Nancy Lee
Chief Regulatory Officer
—
—
—
44,987
0.0624%
$1.66M
—
Wright-Mitchell Jane
Chief Legal Officer
—
—
—
42,403
0.0588%
$1.57M
—
Cheng Andrew
Director
—
—
—
17,488
0.0243%
$647.06K
—

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Young Joseph R
11 Sep 2026
SVP, FINANCE, CHIEF ACCT OFFCR
Exercised, kept
5,000
$3.94
$19.70K
Young Joseph R
13 Mar 2026
SVP, FINANCE, CHIEF ACCT OFFCR
Exercised, kept
10,000
$3.94
$39.40K
Young Joseph R
13 Nov 2025
SVP, FINANCE, CHIEF ACCT OFFCR
Exercised, kept
10,000
$3.94
$39.40K
Fordyce Marshall
19 Dec 2024
PRESIDENT AND CEO
Exercised, kept
57,661
$2.90
$167.03K
Fordyce Marshall
29 Dec 2023
President and CEO
Exercised, kept
13,000
$2.90
$37.66K
Fordyce Marshall
29 Dec 2023
President and CEO
Exercised, kept
516
$2.32
$1.20K
Young Joseph R
5 Jul 2023
SVP, Finance, Chief Acct Offcr
Exercised, kept
10,000
$3.94
$39.40K
Fordyce Marshall
16 Nov 2022
President and CEO
Exercised, kept
60,000
$2.90
$173.81K
Fordyce Marshall
16 Nov 2022
President and CEO
Exercised, kept
5,153
$2.32
$11.94K
Show all 239 transactions →

What was left out

Form 4 filings counted 193
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 139
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 16,126,126
Sales filed before the plan box existed 5
History held since 17 May 2021